Verzenio
Verzenio ingredients
| Active ingredient | Strength |
|---|---|
| Abemaciclib | 50 mg/1, 150 mg/1, 200 mg/1, 100 mg/1 |
What Verzenio is used for
The FDA lists the approved uses on the official label (below). In the EU, abemaciclib is approved as Verzenios for:
Early Breast Cancer Verzenios in combination with endocrine therapy is indicated for the adjuvant treatment of adult patients with hormone receptor (HR) positive, human epidermal growth factor receptor 2 (HER2) negative, node positive early breast cancer at high risk of recurrence (see section 5.1). In pre or perimenopausal women, aromatase inhibitor endocrine therapy should be combined with a luteinising hormone-releasing hormone (LHRH) agonist. Advanced or Metastatic Breast Cancer Verzenios is indicated for the treatment of women with hormone receptor (HR) positive, human epidermal growth factor receptor 2 (HER2) negative locally advanced or metastatic breast cancer in combination with an aromatase inhibitor or fulvestrant as initial endocrine-based therapy, or in women who have received prior endocrine therapy. In pre- or perimenopausal women, the endocrine therapy should be combined …
EU wording from the European Medicines Agency; US approved uses can differ.
Key facts
- Brand
- Verzenio
- Generic name
- Abemaciclib
- Made by
- Eli Lilly and Company
- Forms
- Tablet
- Given
- Oral
- Drug class
- Kinase Inhibitor
- FDA approval
- New drug application (NDA) NDA208716
- On the US market since
- 2017
Official information
- MedlinePlus drug information (search for Abemaciclib)
In India
- Abemaciclib: 3 brands in India
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Verzenio?
Verzenio (Abemaciclib) is a cancer medicine made by Eli Lilly and Company, approved by the US FDA.
What are the ingredients of Verzenio?
Verzenio contains Abemaciclib (50 mg/1, 150 mg/1, 200 mg/1, 100 mg/1).
Is Verzenio approved in Europe?
The same active substance is approved in the EU as Verzenios.
From the FDA National Drug Code directory (open.fda.gov, public domain) and the European Medicines Agency medicines list. Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA